中國動車組列車首次獲簽菲律賓訂單
《新華社》報道,中國中車株洲電力機車有限公司與菲律賓國家鐵路公司18日在菲律賓首都馬尼拉簽署供貨合同,由中國製造的動車組列車將首次出口到菲律賓。
根據合同,中車株機將於2021年7月向菲律賓國家鐵路公司交付3列設計時速為120公里的內燃電力動車組列車。
菲律賓國家鐵路公司總經理洪恩-馬尼奧介紹,這批列車將在馬尼拉和呂宋島南部比科爾地區之間運行,是菲律賓擁有的首批內燃電力動車組列車,預計將極大縮短兩地間的列車運行時間。
據了解,中車株機目前在新加坡、土耳其、馬來西亞、南非、捷克、德國等20多個國家和地區取得了50個軌道交通裝備項目訂單。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.